Chinese investors acquired Australian vitamin maker Vitaco for $239 million
Chinese private equity firm Primavera Capital and Shanghai Pharmaceuticals has acquired Australian vitamins maker Vitaco Holdings for $239 million.
Established in 2007 and employing 400, Vitaco is an Australian supplement manufacturer, distributing in 30 countries and producing 1 billion products every year. Primavera Capital Group is a private equity firm investing in companies in China and around the world. It was founded in 2010 and is based in Beijing with offices in Shanghai and Hong Kong. (According to Reuters, this buyout comes less than a year after Hong Kong-listed Biostime International Holdings bought Australian vitamin maker Swisse Wellness for around $1 billion in 2015).
Primavera Capital is listed in the Chinese Investors Directory with the code SIJ26.
More details follows from Reuters
Previous Post: Chinese firm LeEco acquired US TV maker Vizio for $2 billion
Next Post: Chinese investors of Leyou acquired UK game developer for $150 million